A Workflow to Achieve Saturation of Fluorophore‐Conjugated Monoclonal Antibodies for Robust Comparison of Biomarker Expression

ABSTRACT Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly reproducible results. When aiming to compare antigen expression between samples using mean or median fluorescence intensity (MFI), reagents shoul...

Full description

Saved in:
Bibliographic Details
Published inCytometry. Part A Vol. 107; no. 6; pp. 378 - 389
Main Authors Smith, Natalie, McGuire, Helen, Fazekas de St Groth, Barbara
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.06.2025
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract ABSTRACT Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly reproducible results. When aiming to compare antigen expression between samples using mean or median fluorescence intensity (MFI), reagents should be used at a saturating concentration so that unavoidable variations in staining conditions do not affect the fluorescence signal. The recommended concentrations of commercially available fluorophore‐labeled monoclonal antibodies (mAbs) may not achieve plateau staining, and their saturating concentration may be too high to be experimentally useful. To address these common concerns, we present a novel method to achieve saturation of fluorophore‐conjugated mAbs, by ‘spiking‐in’ unlabelled antibody of the same clone. Here, we demonstrate the application of this workflow to human anti‐CD3 (clone OKT3, mouse IgG2a) and anti‐TCRαβ (clone IP26, mouse IgG1), two mAbs that do not achieve saturation at 2‐fold above their commercially recommended concentrations. First, the saturating concentration of unlabelled (purified) OKT3 and IP26 was determined by detection with a fluorophore‐labeled anti‐mouse IgG (H + L) secondary antibody. Titration curves of unlabelled and labeled mAbs were compared for each clone to determine whether labeling had resulted in any loss in binding activity. Unlabelled antibody was then ‘spiked’ into the labeled antibody at varying ratios, and those that achieved saturation while maintaining an adequate fluorescence signal were identified. We demonstrate that antibody saturation can be achieved with an optimized mixture of labeled and unlabelled antibody, while maintaining a clear signal from the fluorophore. While this workflow has only been applied to OKT3 and IP26, it has potential applicability for any antibody clone for which both labeled and unlabelled preparations are available. This method has significance for robust comparison of biomarker expression when fluorophore labeled reagents do not reach saturation under standard staining conditions.
AbstractList Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly reproducible results. When aiming to compare antigen expression between samples using mean or median fluorescence intensity (MFI), reagents should be used at a saturating concentration so that unavoidable variations in staining conditions do not affect the fluorescence signal. The recommended concentrations of commercially available fluorophore-labeled monoclonal antibodies (mAbs) may not achieve plateau staining, and their saturating concentration may be too high to be experimentally useful. To address these common concerns, we present a novel method to achieve saturation of fluorophore-conjugated mAbs, by 'spiking-in' unlabelled antibody of the same clone. Here, we demonstrate the application of this workflow to human anti-CD3 (clone OKT3, mouse IgG2a) and anti-TCRαβ (clone IP26, mouse IgG1), two mAbs that do not achieve saturation at 2-fold above their commercially recommended concentrations. First, the saturating concentration of unlabelled (purified) OKT3 and IP26 was determined by detection with a fluorophore-labeled anti-mouse IgG (H + L) secondary antibody. Titration curves of unlabelled and labeled mAbs were compared for each clone to determine whether labeling had resulted in any loss in binding activity. Unlabelled antibody was then 'spiked' into the labeled antibody at varying ratios, and those that achieved saturation while maintaining an adequate fluorescence signal were identified. We demonstrate that antibody saturation can be achieved with an optimized mixture of labeled and unlabelled antibody, while maintaining a clear signal from the fluorophore. While this workflow has only been applied to OKT3 and IP26, it has potential applicability for any antibody clone for which both labeled and unlabelled preparations are available. This method has significance for robust comparison of biomarker expression when fluorophore labeled reagents do not reach saturation under standard staining conditions.
ABSTRACT Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly reproducible results. When aiming to compare antigen expression between samples using mean or median fluorescence intensity (MFI), reagents should be used at a saturating concentration so that unavoidable variations in staining conditions do not affect the fluorescence signal. The recommended concentrations of commercially available fluorophore‐labeled monoclonal antibodies (mAbs) may not achieve plateau staining, and their saturating concentration may be too high to be experimentally useful. To address these common concerns, we present a novel method to achieve saturation of fluorophore‐conjugated mAbs, by ‘spiking‐in’ unlabelled antibody of the same clone. Here, we demonstrate the application of this workflow to human anti‐CD3 (clone OKT3, mouse IgG2a) and anti‐TCRαβ (clone IP26, mouse IgG1), two mAbs that do not achieve saturation at 2‐fold above their commercially recommended concentrations. First, the saturating concentration of unlabelled (purified) OKT3 and IP26 was determined by detection with a fluorophore‐labeled anti‐mouse IgG (H + L) secondary antibody. Titration curves of unlabelled and labeled mAbs were compared for each clone to determine whether labeling had resulted in any loss in binding activity. Unlabelled antibody was then ‘spiked’ into the labeled antibody at varying ratios, and those that achieved saturation while maintaining an adequate fluorescence signal were identified. We demonstrate that antibody saturation can be achieved with an optimized mixture of labeled and unlabelled antibody, while maintaining a clear signal from the fluorophore. While this workflow has only been applied to OKT3 and IP26, it has potential applicability for any antibody clone for which both labeled and unlabelled preparations are available. This method has significance for robust comparison of biomarker expression when fluorophore labeled reagents do not reach saturation under standard staining conditions.
Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly reproducible results. When aiming to compare antigen expression between samples using mean or median fluorescence intensity (MFI), reagents should be used at a saturating concentration so that unavoidable variations in staining conditions do not affect the fluorescence signal. The recommended concentrations of commercially available fluorophore-labeled monoclonal antibodies (mAbs) may not achieve plateau staining, and their saturating concentration may be too high to be experimentally useful. To address these common concerns, we present a novel method to achieve saturation of fluorophore-conjugated mAbs, by 'spiking-in' unlabelled antibody of the same clone. Here, we demonstrate the application of this workflow to human anti-CD3 (clone OKT3, mouse IgG2a) and anti-TCRαβ (clone IP26, mouse IgG1), two mAbs that do not achieve saturation at 2-fold above their commercially recommended concentrations. First, the saturating concentration of unlabelled (purified) OKT3 and IP26 was determined by detection with a fluorophore-labeled anti-mouse IgG (H + L) secondary antibody. Titration curves of unlabelled and labeled mAbs were compared for each clone to determine whether labeling had resulted in any loss in binding activity. Unlabelled antibody was then 'spiked' into the labeled antibody at varying ratios, and those that achieved saturation while maintaining an adequate fluorescence signal were identified. We demonstrate that antibody saturation can be achieved with an optimized mixture of labeled and unlabelled antibody, while maintaining a clear signal from the fluorophore. While this workflow has only been applied to OKT3 and IP26, it has potential applicability for any antibody clone for which both labeled and unlabelled preparations are available. This method has significance for robust comparison of biomarker expression when fluorophore labeled reagents do not reach saturation under standard staining conditions.Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly reproducible results. When aiming to compare antigen expression between samples using mean or median fluorescence intensity (MFI), reagents should be used at a saturating concentration so that unavoidable variations in staining conditions do not affect the fluorescence signal. The recommended concentrations of commercially available fluorophore-labeled monoclonal antibodies (mAbs) may not achieve plateau staining, and their saturating concentration may be too high to be experimentally useful. To address these common concerns, we present a novel method to achieve saturation of fluorophore-conjugated mAbs, by 'spiking-in' unlabelled antibody of the same clone. Here, we demonstrate the application of this workflow to human anti-CD3 (clone OKT3, mouse IgG2a) and anti-TCRαβ (clone IP26, mouse IgG1), two mAbs that do not achieve saturation at 2-fold above their commercially recommended concentrations. First, the saturating concentration of unlabelled (purified) OKT3 and IP26 was determined by detection with a fluorophore-labeled anti-mouse IgG (H + L) secondary antibody. Titration curves of unlabelled and labeled mAbs were compared for each clone to determine whether labeling had resulted in any loss in binding activity. Unlabelled antibody was then 'spiked' into the labeled antibody at varying ratios, and those that achieved saturation while maintaining an adequate fluorescence signal were identified. We demonstrate that antibody saturation can be achieved with an optimized mixture of labeled and unlabelled antibody, while maintaining a clear signal from the fluorophore. While this workflow has only been applied to OKT3 and IP26, it has potential applicability for any antibody clone for which both labeled and unlabelled preparations are available. This method has significance for robust comparison of biomarker expression when fluorophore labeled reagents do not reach saturation under standard staining conditions.
Author McGuire, Helen
Smith, Natalie
Fazekas de St Groth, Barbara
Author_xml – sequence: 1
  givenname: Natalie
  orcidid: 0000-0002-9186-2719
  surname: Smith
  fullname: Smith, Natalie
  email: natalie.smith1@sydney.edu.au
  organization: The University of Sydney
– sequence: 2
  givenname: Helen
  orcidid: 0000-0003-2047-6543
  surname: McGuire
  fullname: McGuire, Helen
  organization: The University of Sydney
– sequence: 3
  givenname: Barbara
  orcidid: 0000-0001-6817-9690
  surname: Fazekas de St Groth
  fullname: Fazekas de St Groth, Barbara
  organization: The University of Sydney
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40298242$$D View this record in MEDLINE/PubMed
BookMark eNp90T1v1TAUBmALFdEP2JiRJRYG7sVfcZIxRG1BKqoERYjJcpwT6tvcnGAnlLv1J_Q38ktwSenAwOQzPOeVjt9DsjfgAIQ852zNGRNv3G7CtV0LVcriETngWSZWaWZ7D7MQ--Qwxg1jMmNSPCH7iomyEEockJuKfsFw1fV4TSeklbv08APoJzvNwU4eB4odPelnDDheYoBfN7c1Dpv5m52gpR9wQNfjYHtaDZNvsPUQaYeBfsRmjhOtcTva4OOS89bj1oYrCPT45xggxpT_lDzubB_h2f17RD6fHF_U71Zn56fv6-ps5aTmxSrnqtUNZC2XBYM8c4LnjHety6BxjbAaGNd5KQVrS6s164RQnWWCyVKDbJQ8Iq-W3DHg9xniZLY-Ouh7OwDO0Uheas0zJfNEX_5DNziHdGRSQpS5YnleJPXiXs3NFlozBp-O25m_f5vA6wW4gDEG6B4IZ-auOnNXnbHmT3WJq4Vf-x52_7Wm_npxXi1rvwErHJ5s
Cites_doi 10.1016/S0090-8258(03)00009-X
10.7554/eLife.04333
10.1002/cpz1.589
10.1002/cyto.b.20158
10.1002/cyto.b.22155
10.1093/clinchem/31.8.1264
10.1002/(sici)1097‐0320(19980601)32:23.0.co;2‐g
10.1080/00032719608001447
10.1002/0471142956.cy0629s54
10.1002/ijc.24137
10.1002/ijc.2910610605
10.1111/j.1365-2257.1996.tb00728.x
10.1172/JCI1457
10.1007/978-1-0716-2217-9_4
10.3892/ol.2016.4209
10.1016/0008-8749(92)90321-F
10.1111/j.1365-2141.2000.02415.x
10.1182/blood.V88.9.3513.bloodjournal8893513
10.1002/cyto.a.21147
10.1042/BSR20203827
10.1038/483531a
10.1155/2020/1039458
10.1038/nprot.2006.268
10.1016/0161-5890(85)90029-X
10.1002/eji.202170126
10.3390/cells13201677
10.1002/cyto.a.20092
10.1016/0022-1759(86)90072-4
ContentType Journal Article
Copyright 2025 The Author(s). published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry.
2025 The Author(s). Cytometry Part A published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry.
2025. This work is published under Creative Commons Attribution License~https://creativecommons.org/licenses/by/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2025 The Author(s). published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry.
– notice: 2025 The Author(s). Cytometry Part A published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry.
– notice: 2025. This work is published under Creative Commons Attribution License~https://creativecommons.org/licenses/by/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7TK
8FD
FR3
P64
7X8
DOI 10.1002/cyto.a.24938
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
CrossRef
Engineering Research Database
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1552-4930
EndPage 389
ExternalDocumentID 40298242
10_1002_cyto_a_24938
CYTOA24938
Genre researchArticle
Journal Article
GrantInformation_xml – fundername: an Australian Government Research Training Program (RTP)
– fundername: National Health and Medical Research Council
  funderid: 2014538
– fundername: National Health and Medical Research Council
  grantid: 2014538
GroupedDBID ---
-~X
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OC
24P
2WC
31~
33P
3SF
4.4
4ZD
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHQN
AAMMB
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABLJU
ABPVW
ACAHQ
ACCZN
ACFBH
ACGFS
ACIWK
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEFGJ
AEGXH
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFFPM
AFGKR
AFRAH
AFWVQ
AFZJQ
AGHNM
AGXDD
AGYGG
AHBTC
AIDQK
AIDYY
AITYG
AIURR
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AUFTA
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CO8
CS3
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRSTM
DU5
E3Z
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
P2P
P2W
P2X
P4D
Q.N
QB0
QRW
R.K
RNS
ROL
SUPJJ
SV3
UB1
V2E
W8V
W99
WBKPD
WIH
WIK
WIN
WJL
WNSPC
WOHZO
WQJ
WXSBR
WYISQ
XG1
XV2
ZZTAW
~IA
~KM
~WT
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7TK
8FD
FR3
P64
7X8
ID FETCH-LOGICAL-c3618-714d6be5d1380e75c21701fdc5ebcb2a6e01679320d9a660f224fa020396e3b43
IEDL.DBID DR2
ISSN 1552-4922
1552-4930
IngestDate Fri Jul 11 18:27:59 EDT 2025
Tue Jul 29 17:51:11 EDT 2025
Tue Jul 15 01:30:38 EDT 2025
Thu Jul 24 02:02:55 EDT 2025
Wed Jul 30 09:30:34 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords titration
antibody saturation
flow cytometry
Language English
License Attribution
2025 The Author(s). Cytometry Part A published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3618-714d6be5d1380e75c21701fdc5ebcb2a6e01679320d9a660f224fa020396e3b43
Notes Funding
This work was supported by National Health and Medical Research Council, 2014538. N. Smith is supported by an Australian Government Research Training Program (RTP) scholarship.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-9186-2719
0000-0003-2047-6543
0000-0001-6817-9690
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcyto.a.24938
PMID 40298242
PQID 3229740778
PQPubID 2045167
PageCount 12
ParticipantIDs proquest_miscellaneous_3196615437
proquest_journals_3229740778
pubmed_primary_40298242
crossref_primary_10_1002_cyto_a_24938
wiley_primary_10_1002_cyto_a_24938_CYTOA24938
PublicationCentury 2000
PublicationDate June 2025
PublicationDateYYYYMMDD 2025-06-01
PublicationDate_xml – month: 06
  year: 2025
  text: June 2025
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
– name: Hoboken
PublicationTitle Cytometry. Part A
PublicationTitleAlternate Cytometry A
PublicationYear 2025
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2010; 54
1986; 90
2012; 483
1996; 18
2022; 2475
2004; 62
2024; 106
1992; 145
2011; 79
2007; 72
2000; 111
2006; 1
2024; 13
1985; 22
1999; 5
2021; 51
2016; 11
1995; 61
2021; 10
1996; 29
2020; 2020
2014; 3
2001; 7
2009; 124
2001; 1
2022; 2
1998; 32
1996; 2
2021; 41
1985; 31
1998; 101
2003; 89
1996; 88
Kuss I. (e_1_2_11_6_1) 1999; 5
e_1_2_11_10_1
e_1_2_11_32_1
e_1_2_11_31_1
e_1_2_11_30_1
e_1_2_11_14_1
e_1_2_11_13_1
e_1_2_11_34_1
e_1_2_11_11_1
e_1_2_11_33_1
e_1_2_11_7_1
e_1_2_11_29_1
e_1_2_11_28_1
e_1_2_11_5_1
e_1_2_11_27_1
e_1_2_11_26_1
e_1_2_11_3_1
Kono K. (e_1_2_11_4_1) 1996; 2
Stewart C. C. (e_1_2_11_18_1) 2001; 1
Dworacki G. (e_1_2_11_2_1) 2001; 7
e_1_2_11_21_1
e_1_2_11_20_1
e_1_2_11_25_1
e_1_2_11_24_1
e_1_2_11_9_1
e_1_2_11_23_1
e_1_2_11_8_1
Errington T. M. (e_1_2_11_12_1) 2021; 10
e_1_2_11_22_1
e_1_2_11_17_1
e_1_2_11_16_1
e_1_2_11_15_1
e_1_2_11_19_1
References_xml – volume: 7
  start-page: 947s
  issue: S3
  year: 2001
  end-page: 957s
  article-title: Decreased Zeta Chain Expression and Apoptosis in CD3+ Peripheral Blood T Lymphocytes of Patients With Melanoma
  publication-title: Clinical Cancer Research
– volume: 22
  start-page: 11
  issue: 1
  year: 1985
  end-page: 21
  article-title: Kinetics of Divalent Monoclonal Antibody Binding to Tumour Cell Surface Antigens Using Flow Cytometry: Standardization and Mathematical Analysis
  publication-title: Molecular Immunology
– volume: 11
  start-page: 2199
  issue: 3
  year: 2016
  end-page: 2206
  article-title: Development of a Standardized Flow Cytometric Method to Conduct Longitudinal Analyses of Intracellular CD3zeta Expression in Patients With Head and Neck Cancer
  publication-title: Oncology Letters
– volume: 145
  start-page: 175
  issue: 1
  year: 1992
  end-page: 186
  article-title: The CD45RO (p180, UCHL1) Marker: Complexity of Expression in Peripheral Blood
  publication-title: Cellular Immunology
– volume: 5
  start-page: 329
  issue: 2
  year: 1999
  end-page: 334
  article-title: Clinical Significance of Decreased Zeta Chain Expression in Peripheral Blood Lymphocytes of Patients With Head and Neck Cancer
  publication-title: Clinical Cancer Research
– volume: 111
  start-page: 817
  issue: 3
  year: 2000
  end-page: 825
  article-title: Impaired Expression of the CD3‐Zeta Chain in Peripheral Blood T Cells of Patients With Chronic Myeloid Leukaemia Results in an Increased Susceptibility to Apoptosis
  publication-title: British Journal of Haematology
– volume: 88
  start-page: 3513
  issue: 9
  year: 1996
  end-page: 3521
  article-title: Heterogeneity of the Human CD4+ T‐Cell Population: Two Distinct CD4+ T‐Cell Subsets Characterized by Coexpression of CD45RA and CD45RO Isoforms
  publication-title: Blood
– volume: 101
  start-page: 1448
  issue: 7
  year: 1998
  end-page: 1457
  article-title: Altered Pattern of TCR/CD3‐Mediated Protein‐Tyrosyl Phosphorylation in T Cells From Patients With Systemic Lupus Erythematosus. Deficient Expression of the T Cell Receptor Zeta Chain
  publication-title: Journal of Clinical Investigation
– volume: 90
  start-page: 165
  issue: 2
  year: 1986
  end-page: 172
  article-title: Measurement of Tumour Reactive Antibody and Antibody Conjugate by Competition, Quantitated by Flow Cytofluorimetry
  publication-title: Journal of Immunological Methods
– volume: 1
  start-page: 1507
  issue: 3
  year: 2006
  end-page: 1516
  article-title: Intracellular Cytokine Optimization and Standard Operating Procedure
  publication-title: Nature Protocols
– volume: 32
  start-page: 109
  issue: 2
  year: 1998
  end-page: 119
  article-title: Impaired Expression and Function of Signal‐Transducing Zeta Chains in Peripheral T Cells and Natural Killer Cells in Patients With Prostate Cancer
  publication-title: Cytometry
– volume: 62
  start-page: 169
  issue: 2
  year: 2004
  end-page: 173
  article-title: Selecting Fluorochrome Conjugates for Maximum Sensitivity
  publication-title: Cytometry, Part A
– volume: 61
  start-page: 765
  issue: 6
  year: 1995
  end-page: 772
  article-title: Alterations in the Signal‐Transducing Molecules of T Cells and NK Cells in Colorectal Tumor‐Infiltrating, Gut Mucosal and Peripheral Lymphocytes: Correlation With the Stage of the Disease
  publication-title: International Journal of Cancer
– volume: 2020
  year: 2020
  article-title: Defects at the Posttranscriptional Level Account for the Low TCRzeta Chain Expression Detected in Gastric Cancer Independently of Caspase‐3 Activity
  publication-title: Journal of Immunology Research
– volume: 3
  start-page: 3
  year: 2014
  article-title: An Open Investigation of the Reproducibility of Cancer Biology Research
  publication-title: eLife
– volume: 2475
  start-page: 61
  year: 2022
  end-page: 77
  article-title: Absolute Quantification of Plasma Membrane Receptors via Quantitative Flow Cytometry
  publication-title: Methods in Molecular Biology
– volume: 124
  start-page: 1605
  issue: 7
  year: 2009
  end-page: 1613
  article-title: Mechanisms Involved in the Down‐Regulation of TCR Zeta Chain in Tumor Versus Peripheral Blood of Oral Cancer Patients
  publication-title: International Journal of Cancer
– volume: 18
  start-page: 1
  issue: 1
  year: 1996
  end-page: 5
  article-title: Use and Evaluation of Leucocyte Monoclonal Antibodies in the Diagnostic Laboratory: A Review
  publication-title: Clinical and Laboratory Haematology
– volume: 51
  start-page: 2708
  issue: 12
  year: 2021
  end-page: 3145
  article-title: Guidelines for the Use of Flow Cytometry and Cell Sorting in Immunological Studies (Third Edition)
  publication-title: European Journal of Immunology
– volume: 79
  start-page: 990
  issue: 12
  year: 2011
  end-page: 999
  article-title: Fluorescent Particles in the Antibody Solution Result in False TF‐ and CD14‐Positive Microparticles in Flow Cytometric Analysis
  publication-title: Cytometry. Part A
– volume: 2
  start-page: 1825
  issue: 11
  year: 1996
  end-page: 1828
  article-title: Decreased Expression of Signal‐Transducing Zeta Chain in Peripheral T Cells and Natural Killer Cells in Patients With Cervical Cancer
  publication-title: Clinical Cancer Research
– volume: 54
  start-page: 6
  issue: 1
  year: 2010
  end-page: 29
  article-title: Titration of Fluorochrome‐Conjugated Antibodies for Labeling Cell Surface Markers on Live Cells
  publication-title: Current Protocols in Cytometry
– volume: 1
  start-page: 1
  year: 2001
  end-page: 4
  article-title: Titering Antibodies
  publication-title: Current Protocols in Cytometry
– volume: 483
  start-page: 531
  issue: 7391
  year: 2012
  end-page: 533
  article-title: Drug Development: Raise Standards for Preclinical Cancer Research
  publication-title: Nature
– volume: 31
  start-page: 1264
  issue: 8
  year: 1985
  end-page: 1271
  article-title: Guidelines for Immunoassay Data Processing
  publication-title: Clinical Chemistry
– volume: 72
  start-page: 223
  issue: 3
  year: 2007
  end-page: 226
  article-title: Statistical Criteria to Establish Optimal Antibody Dilution in Flow Cytometry Analysis
  publication-title: Cytometry Part B: Clinical Cytometry
– volume: 106
  start-page: 25
  issue: 1
  year: 2024
  end-page: 34
  article-title: Standardization of Flow Cytometric Detection of Antigen Expression
  publication-title: Cytometry. Part B, Clinical Cytometry
– volume: 89
  start-page: 120
  issue: 1
  year: 2003
  end-page: 128
  article-title: No Alteration in NK Function or Zeta Chain Expression in NK and T Cells of Cervical Cancer Patients
  publication-title: Gynecologic Oncology
– volume: 10
  start-page: 10
  year: 2021
  article-title: Investigating the Replicability of Preclinical Cancer Biology
  publication-title: eLife
– volume: 13
  issue: 20
  year: 2024
  article-title: The Power of Reagent Titration in Flow Cytometry
  publication-title: Cells
– volume: 2
  issue: 11
  year: 2022
  article-title: Do More With Less: Improving High Parameter Cytometry Through Overnight Staining
  publication-title: Current Protocols
– volume: 29
  start-page: 953
  issue: 6
  year: 1996
  end-page: 968
  article-title: Assessment of the Effect of Increased Fluorophore Labelling on the Binding Ability of an Antibody
  publication-title: Analytical Letters
– volume: 41
  issue: 2
  year: 2021
  article-title: Effects of Storage Time and Temperature on Highly Multiparametric Flow Analysis of Peripheral Blood Samples; Implications for Clinical Trial Samples
  publication-title: Bioscience Reports
– ident: e_1_2_11_14_1
  doi: 10.1016/S0090-8258(03)00009-X
– ident: e_1_2_11_11_1
  doi: 10.7554/eLife.04333
– ident: e_1_2_11_30_1
  doi: 10.1002/cpz1.589
– volume: 2
  start-page: 1825
  issue: 11
  year: 1996
  ident: e_1_2_11_4_1
  article-title: Decreased Expression of Signal‐Transducing Zeta Chain in Peripheral T Cells and Natural Killer Cells in Patients With Cervical Cancer
  publication-title: Clinical Cancer Research
– ident: e_1_2_11_26_1
  doi: 10.1002/cyto.b.20158
– ident: e_1_2_11_34_1
  doi: 10.1002/cyto.b.22155
– ident: e_1_2_11_32_1
  doi: 10.1093/clinchem/31.8.1264
– ident: e_1_2_11_3_1
  doi: 10.1002/(sici)1097‐0320(19980601)32:23.0.co;2‐g
– ident: e_1_2_11_22_1
  doi: 10.1080/00032719608001447
– ident: e_1_2_11_17_1
  doi: 10.1002/0471142956.cy0629s54
– volume: 7
  start-page: 947s
  issue: 3
  year: 2001
  ident: e_1_2_11_2_1
  article-title: Decreased Zeta Chain Expression and Apoptosis in CD3+ Peripheral Blood T Lymphocytes of Patients With Melanoma
  publication-title: Clinical Cancer Research
– volume: 10
  start-page: 10
  year: 2021
  ident: e_1_2_11_12_1
  article-title: Investigating the Replicability of Preclinical Cancer Biology
  publication-title: eLife
– ident: e_1_2_11_9_1
  doi: 10.1002/ijc.24137
– ident: e_1_2_11_5_1
  doi: 10.1002/ijc.2910610605
– ident: e_1_2_11_16_1
  doi: 10.1111/j.1365-2257.1996.tb00728.x
– ident: e_1_2_11_10_1
  doi: 10.1172/JCI1457
– ident: e_1_2_11_33_1
  doi: 10.1007/978-1-0716-2217-9_4
– ident: e_1_2_11_15_1
  doi: 10.3892/ol.2016.4209
– ident: e_1_2_11_29_1
  doi: 10.1016/0008-8749(92)90321-F
– ident: e_1_2_11_7_1
  doi: 10.1111/j.1365-2141.2000.02415.x
– ident: e_1_2_11_28_1
  doi: 10.1182/blood.V88.9.3513.bloodjournal8893513
– ident: e_1_2_11_31_1
  doi: 10.1002/cyto.a.21147
– volume: 5
  start-page: 329
  issue: 2
  year: 1999
  ident: e_1_2_11_6_1
  article-title: Clinical Significance of Decreased Zeta Chain Expression in Peripheral Blood Lymphocytes of Patients With Head and Neck Cancer
  publication-title: Clinical Cancer Research
– ident: e_1_2_11_25_1
  doi: 10.1042/BSR20203827
– ident: e_1_2_11_13_1
  doi: 10.1038/483531a
– ident: e_1_2_11_8_1
  doi: 10.1155/2020/1039458
– volume: 1
  start-page: 1
  year: 2001
  ident: e_1_2_11_18_1
  article-title: Titering Antibodies
  publication-title: Current Protocols in Cytometry
– ident: e_1_2_11_27_1
  doi: 10.1038/nprot.2006.268
– ident: e_1_2_11_23_1
  doi: 10.1016/0161-5890(85)90029-X
– ident: e_1_2_11_19_1
  doi: 10.1002/eji.202170126
– ident: e_1_2_11_20_1
  doi: 10.3390/cells13201677
– ident: e_1_2_11_21_1
  doi: 10.1002/cyto.a.20092
– ident: e_1_2_11_24_1
  doi: 10.1016/0022-1759(86)90072-4
SSID ssj0035032
Score 2.4193518
Snippet ABSTRACT Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly...
Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly reproducible...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 378
SubjectTerms Animals
Antibodies, Monoclonal - chemistry
Antibodies, Monoclonal - immunology
antibody saturation
Biomarkers
Biomarkers - analysis
CD3 antigen
CD3 Complex - immunology
flow cytometry
Flow Cytometry - methods
Fluorescence
Fluorescent Dyes - chemistry
Humans
Immunoglobulin G
Immunoglobulin G - immunology
Mice
Monoclonal antibodies
Reagents
Robustness
Saturation
Staining
Staining and Labeling - methods
Titration
Workflow
Title A Workflow to Achieve Saturation of Fluorophore‐Conjugated Monoclonal Antibodies for Robust Comparison of Biomarker Expression
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcyto.a.24938
https://www.ncbi.nlm.nih.gov/pubmed/40298242
https://www.proquest.com/docview/3229740778
https://www.proquest.com/docview/3196615437
Volume 107
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BJSQuvB8LpTISHLPN2o6TPa5WXVVIPFRaqZws23HUwhJXuwlQTv0J_EZ-CTNONlCQkOAWKfEjHo_9eTzzDcCzvPKV9CpLKLc2HlCETEzhikRxI3C7mDpbUrzzy1dq_0i-OM6Oe4MbxcJ0_BCDwY00I67XpODGrnd_koa68yaMzRiPD4JifcldizDRwcAeJbI05icjkrFETjnv_d6x-O6vhS_vSH_AzMuoNW47i5ugNx3uvE0-jNvGjt3X37gc__-PbsGNHpGyWTeFbsMVX9-Ba12OyvO7cDFjZFCvluEzawKbuZNT_8mzt0QIGqXKQsUWyzaswtlJWPnvF9_moX7fknmuZLhkBLcMsYG6ObWBnBYZAmV2EGy7bth8yINI9WCrH8lfaMX2vvQeuvU9OFrsHc73kz5tQ-KEmhQk9VJZn5UTUaQ-zxwnzveqdJm3znKjPIU-IG5My6lRKq0QRVSGbkSnygsrxX3YqkPtHwKbeO6Uy2VaZVxaLFuq3GZOiVIqIfJiBM83otNnHTuH7niYuabR1EbH0RzB9kauutfRtcalDA9TaU7VPB1eo3bRlYmpfWjxG1ygEPNJkY_gQTcfhoYksdcjwhlBEqX61x7o-bvD17P4-Ogfv38M1zklHY6mn23Yalatf4JIqLE7cJXLNztx1v8AUYsHFw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB5BEaIXym9ZKGAkOGabjR0ne1ytulqgLVLZSuVkYsdRS7dxtU2Acuoj9Bl5EmacbKAgISFukRL_xOOxvxmPvwF4mRS2EFbGAeXWRgOFiyBLTRrIKOO4XQyNzum-886unO6LNwfxQZvnlO7CNPwQncONNMOv16Tg5JDe_Mkaas4r18_6aD_w9DrcoKTe3qba6_ijeBz6DGVEMxaIYRS1ke9YfvPX0lf3pD-A5lXc6jeeyRp8XHa5iTc57teV7ptvv7E5_sc_3YHbLShlo2YW3YVrtrwHN5s0lef34WLEyKdezN0XVjk2ModH9rNl74kT1AuWuYJN5rVbuNNDt7DfLy7HrvxUk4cuZ7hqODN3voGyOtKO4hYZYmW253R9VrFxlwqR6sFWTyhkaMG2vrZBuuUD2J9szcbToM3cEBguBykJPpfaxvmAp6FNYhMR7XuRm9hqo6NMWrr9gNAxzIeZlGGBQKLI6FB0KC3Xgj-EldKV9hGwgY2MNIkIizgSGsvmMtGxkTwXkvMk7cGrpezUaUPQoRoq5kjRaKpM-dHswcZSsKpV0zOFqxnaU2FC1bzoXqOC0alJVlpX4ze4RiHsEzzpwXozIbqGBBHYI8jpQeDF-tceqPGH2buRf3z8j98_h1vT2c622n69-_YJrEaUg9h7gjZgpVrU9ikCo0o_85P_B3gSCls
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BEYgL78dCASPBMdus7TjZ42rbVXkVVFqpnKz4pRaWeLVNgHLqT-A38kvwONlAQUKCW6TEj3hm7M_j8TcAT3JnHbciSzC3dtigMJ6UhS4SQUsWlouxVgbvO7_aEdv7_PlBdtA53PAuTMsP0Tvc0DLifI0GvjBu4ydpqD6p_bAchu0DK87DBS7SArV6c7enj2JZGhOUIctYwseUdoHvofzGr6XPLkl_4MyzsDWuO7OrIFc9bsNNPgybWg3119_IHP__l67BlQ6SkkmrQ9fhnK1uwMU2SeXJTTidEPSou7n_TGpPJvrwyH6y5C0ygkaxEu_IbN74pV8c-qX9fvpt6qv3DfrnDAlzhtdzHxuo6iPlMWqRBKRMdr1qjmsy7RMhYj2h1Y8YMLQkW1-6EN3qFuzPtvam20mXtyHRTIwKFLsRymZmxIrU5pmmSPrujM6s0oqWwuLdhwAcUzMuhUhdgBGuxCPRsbBMcXYb1ipf2btARpZqoXOeuoxyFcoakatMC2a4YCwvBvB0JTq5aOk5ZEvETCWOpixlHM0BrK_kKjsjPZZhLgu7qTTHah73r4N54ZlJWVnfhG_CDBVAH2f5AO60-tA3xJG-PkCcASRRqn_tgZy-23s9iY_3_vH7R3DpzeZMvny28-I-XKaYgDi6gdZhrV429kFARbV6GFX_B3flCRM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Workflow+to+Achieve+Saturation+of+Fluorophore%E2%80%90Conjugated+Monoclonal+Antibodies+for+Robust+Comparison+of+Biomarker+Expression&rft.jtitle=Cytometry.+Part+A&rft.au=Smith%2C+Natalie&rft.au=McGuire%2C+Helen&rft.au=Fazekas+de+St+Groth%2C+Barbara&rft.date=2025-06-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1552-4922&rft.eissn=1552-4930&rft.volume=107&rft.issue=6&rft.spage=378&rft.epage=389&rft_id=info:doi/10.1002%2Fcyto.a.24938&rft.externalDBID=10.1002%252Fcyto.a.24938&rft.externalDocID=CYTOA24938
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-4922&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-4922&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-4922&client=summon